Pharmaceuticals FDA grants accelerated approval to Amgen’s Imdeltora to treat adults with advanced small cell lung cancer Last updated: May 17, 2024 3:17 pm By bexib 0 Min Read Share SHARE Imdelltra (tarlatamab-dlle) is the first T-cell engager therapy approved for extensive-stage small cell lung cancer. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article The best email marketing tells a story Next Article Exciting American-themed bar and restaurant opens in Liverpool’s iconic cultural quarter Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Germany, Japan, and Telangana – Econlib Economy This week’s real estate newsletter article: September new home sales rise to annualized rate of 738,000 units Economy The Socialist Calculation Debate: Theory in Practice. Economy Schedule for the week of October 27, 2024 Economy